Clostridioides difficile: Treating Sustained Antibiotic Responders With Fecal Microbiota Transplantation Does Not Improve Efficacy | Synapse
March 1, 2026
Clostridioides difficile: Treating Sustained Antibiotic Responders With Fecal Microbiota Transplantation Does Not Improve Efficacy
Key Points
This correspondence examines the efficacy of fecal microbiota transplantation for individuals who respond to antibiotics for Clostridioides difficile infections.
Assessment of fecal microbiota transplantation in sustained antibiotic responders
Comparison of treatment outcomes with standard antibiotic therapy
Fecal microbiota transplantation does not enhance treatment efficacy in antibiotic responders
No significant improvement was observed in patient outcomes compared to standard care